Elucidating the therapeutic mechanisms of resveratrol in benign prostatic hyperplasia via an integrated strategy of network pharmacology, multi-omics and molecular biology
{{output}}
Background: Benign prostatic hyperplasia (BPH) is a prevalent age-associated urological disorder marked by excessive proliferation of epithelial and stromal cells within the prostate. Resveratrol (Res), a naturally occurring poly... ...
